EHAB Form 4: Hospice EVP Doubles Stake with 22.8K-Share Purchase

Rhea-AI Filing Summary

Enhabit, Inc. (EHAB) Form 4 filed 08/07/2025 discloses an insider purchase. EVP of Hospice Operations Jeanne L. Kalvaitis acquired 22,795 shares of common stock on 08/05/2025 at an indicated price of $6.69 under transaction code “A” (award or purchase). Following the transaction, her direct ownership doubled to 45,979 shares.

No derivative transactions were reported. The filing reflects a single-person submission with direct ownership only and contains no additional remarks or explanations.

Positive

• Insider acquisition: EVP Jeanne Kalvaitis bought/was awarded 22,795 shares, boosting direct stake to 45,979 shares.
• Price point: Purchase at $6.69 could indicate management views shares as undervalued.

Negative

• None.

Insights

Securities Analyst

TL;DR: Officer doubled stake, modest share count but insider buying is a constructive signal.

The EVP’s purchase of 22.8k shares at $6.69 lifts her direct holdings to 45.9k shares, suggesting personal confidence in EHAB’s valuation after recent price weakness. Although the dollar value is relatively small (<$0.2 m), any open-market or awarded acquisition by senior management is typically viewed positively, highlighting perceived upside or alignment with shareholders. No sales or derivative hedges were disclosed, reinforcing a cleaner bullish stance. Impact is limited by transaction size but directionally positive.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalvaitis Jeanne Louise

(Last) (First) (Middle)

6688 N. CENTRAL EXPRESSWAY

SUITE 1300

(Street)

DALLAS TX 75206

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enhabit, Inc. [ EHAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP of Hospice Operations

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2025		A		22,795	A	$6.69	45,979	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Sarah W. Braley, Attorney in Fact	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Enhabit (EHAB) report in its latest Form 4?

EVP Jeanne L. Kalvaitis acquired 22,795 EHAB common shares on 08/05/2025, doubling her direct holdings to 45,979.

At what price were the EHAB shares acquired?

The filing lists a price of $6.69 per share for the 22,795 shares.

How many EHAB shares does the EVP now own?

Post-transaction, Kalvaitis directly owns 45,979 common shares.

Was this an open-market purchase or an award?

Transaction code “A” denotes an acquisition/award; the filing does not specify further.

Were any derivative securities involved?

No. Table II shows no derivative transactions reported.